Literature DB >> 30579076

Occult malignancy in pediatric tonsil and adenoid surgeries - A national survey.

Guy Lifshitz1, Maayan Gruber2, Ohad Ronen3.   

Abstract

OBJECTIVE: To evaluate the incidence of tonsil and adenoid malignancy in pediatric patients in Israel compared to the known literature and to revisit the common practice of routine histopathologic examination of tonsils and adenoids.
METHODS: Analysis of the Israel National Cancer Registry data on pediatric tonsil and adenoid malignancies between the years 2005 and 2015, and a systematic literature review of all relevant articles that reported on malignancies amongst pediatric patients who underwent tonsillectomy with or without adenoidectomy.
RESULTS: Only seven cases of tonsillar malignancies were documented out of 152,352 (0.0052%) surgeries in the pediatric population. All malignancies were lymphoproliferative and mainly Burkitt's lymphoma. In our medical center no malignancy was found in 2165 patients in the same age groups and time period. We found the incidence of tonsillar malignancy in Israel to be significantly lower (p = 0.013) compared to the previously described literature.
CONCLUSION: The incidence of malignancy in routine histopathological examination of tonsils and adenoids is Israel is very low when compared to the known literature. According to these results, we suggest that routine histopathological examination of all such samples is not clinically justified.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenoidectomy; Lymphoma; Occult malignancy; Pediatric; Tonsillectomy

Mesh:

Year:  2018        PMID: 30579076     DOI: 10.1016/j.ijporl.2018.11.031

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  1 in total

1.  Tonsillectomy and hematologic malignancy: Should routine pediatric tonsillectomy specimens be sent to pathology?

Authors:  Kaitlyn Tholen; Olivia Kalmanson; Christian R Francom; Jeremy D Prager
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2021-09-27       Impact factor: 1.675

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.